It's official—AbbVie dumps Rova-T after another lung cancer fail - FierceBiotech

It's official—AbbVie dumps Rova-T after another lung cancer fail  FierceBiotech

Lung cancer patients taking Rova-T as a frontline treatment didn't outlive those on placebo, prompting a committee to recommend AbbVie halt the study.